BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2020
View Archived Issues
Linking two liver cancer culprits
Read More
Functional analysis complements sequencing
Read More
Cerevance presents phase Ib data on CVN-058 for schizophrenia cognition
Read More
Lundbeck identifies new Kv3.1 potassium channel activators
Read More
Designed Cells, Chungbuk National University patent stem cell-derived exosome-rich culture medium
Read More
New phenothiazine derivative antibacterials discovered at the University of Copenhagen
Read More
Osaka University presents new histone demethylase inhibitors
Read More
New alpha-2B adrenoceptor antagonists described by Bayer
Read More
First-in-human PK data presented for ZM-H1505R, a novel HBV capsid assembly modulator
Read More
Positive 12-month data for AAV-RPGR in X-linked retinitis pigmentosa
Read More
Ependymomas may respond to PARP inhibitors
Read More
Biological E's novel COVID-19 subunit vaccine candidate enters phase I/II development
Read More
First-in-human interim results of ALN-AGT01 in patients with hypertension
Read More
Kangpu opens phase Ib/IIa study to evaluate KPG-818 in SLE
Read More
Inovio opens phase II segment of phase II/III study evaluating COVID-19 vaccine candidate INO-4800
Read More
Artelo receives clearance for phase I/II trial of ART-27.13 in cancer anorexia
Read More
FDA clears IND application for phase II study of NT-I7 plus atezolizumab in NSCLC
Read More
Phase III trial shows efficacy and safety of intravenous immunoglobulin in treating dermatomyositis
Read More
Innovent presents phase I data on IBI-302 for neovascular AMD
Read More
Bispecific 4-1BBx5T4 antibody ALG.APV-527 advancing towards clinic
Read More
IBI-188 does not show single-agent activity in phase I study, warrants further combination studies
Read More
Tofacitinib demonstrates long-term safety and efficacy in refractory dermatomyositis
Read More
FDA clears initiation of phase II trials of NBTXR-3 in HNSCC
Read More
TrippBio reports viral clearance in trial of TD-213 for mild to moderate COVID-19
Read More
HMGXB4 correlates with vascular inflammation and SMC phenotypic switching
Read More